Stock Research for CTIC

CTIC

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CTIC Stock Chart & Research Data

The CTIC chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CTIC chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CTIC Due diligence Resources & Stock Charts

The CTIC stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CTIC Detailed Price Forecast - CNN Money CNN View CTIC Detailed Summary - Google Finance
Yahoo View CTIC Detailed Summary - Yahoo! Finance Zacks View CTIC Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View CTIC Trends & Analysis - Trade-Ideas Barrons View CTIC Major Holders - Barrons
NASDAQ View CTIC Call Transcripts - NASDAQ Seeking View CTIC Breaking News & Analysis - Seeking Alpha
Spotlight View CTIC Annual Report - CompanySpotlight.com OTC Report View CTIC OTC Short Report - OTCShortReport.com
TradeKing View CTIC Fundamentals - TradeKing Charts View CTIC SEC Filings - Bar Chart
WSJ View Historical Prices for CTIC - The WSJ Morningstar View Performance/Total Return for CTIC - Morningstar
MarketWatch View the Analyst Estimates for CTIC - MarketWatch CNBC View the Earnings History for CTIC - CNBC
StockMarketWatch View the CTIC Earnings - StockMarketWatch MacroAxis View CTIC Buy or Sell Recommendations - MacroAxis
Bullish View the CTIC Bullish Patterns - American Bulls Short Pains View CTIC Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View CTIC Stock Mentions - StockTwits PennyStocks View CTIC Stock Mentions - PennyStockTweets
Twitter View CTIC Stock Mentions - Twitter Invest Hub View CTIC Investment Forum News - Investor Hub
Yahoo View CTIC Stock Mentions - Yahoo! Message Board Seeking Alpha View CTIC Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for CTIC - SECform4.com Insider Cow View Insider Transactions for CTIC - Insider Cow
CNBC View CTIC Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CTIC - OTC Markets
Yahoo View Insider Transactions for CTIC - Yahoo! Finance NASDAQ View Institutional Holdings for CTIC - NASDAQ


Stock Charts

FinViz View CTIC Stock Insight & Charts - FinViz.com StockCharts View CTIC Investment Charts - StockCharts.com
BarChart View CTIC Stock Overview & Charts - BarChart Trading View View CTIC User Generated Charts - Trading View




Latest Financial News for CTIC


CTI BioPharma Announces Restructuring Plan
Posted on Thursday December 13, 2018

SEATTLE, Dec. 13, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTIC) announced today a restructuring plan to improve efficiencies and reduce costs within the organization. As part of this plan, workforce reductions have been implemented that impact approximately 50 percent of the total number of the Company's employees. Cost savings of approximately $20 million primarily associated with reduced employee costs are expected over three years.


CTI BioPharma Provides Program Update Following Regulatory Feedback on Pacritinib Development from the European Medicines Agency
Posted on Monday November 26, 2018

SEATTLE, Nov. 26, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTIC) today announced that the Company has received a second round of questions related to the Day 180 List of Outstanding Issues, for the marketing authorization application (MAA) for pacritinib, from the European Medicines Agency (EMA). The Company plans to submit responses to the EMA, which will include data from the ongoing open label PAC203 trial, by the end of the year.


Detailed Research: Economic Perspectives on Jason Industries, XBiotech, Dynatronics, Evolving, CTI BioPharma, and Charles & Colvard — What Drives Growth in Today's Competitive Landscape
Posted on Friday November 23, 2018

NEW YORK, Nov. 23, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.


CTI BioPharma (CTIC) Reports Q3 Loss, Tops Revenue Estimates
Posted on Thursday November 01, 2018

CTI BioPharma (CTIC) delivered earnings and revenue surprises of -30.00% and 20.50%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?


Stock Market & Investing Books

Enter a stock symbol to view the stock details.